We are live on ! Find out more
CI

Clal Insurance Portfolio holdings

AUM $16.6B
1-Year Est. Return 68.34%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+68.34%
3 Year Est. Return
+151.82%
5 Year Est. Return
+175.48%
10 Year Est. Return
+729.64%
AUM
$4.08B
AUM Growth
+$235M
Cap. Flow
-$328M
Cap. Flow %
-8.02%
Top 10 Hldgs %
42.3%
Holding
117
New
17
Increased
24
Reduced
42
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Financials 6.81%
3 Communication Services 5.99%
4 Healthcare 5.71%
5 Industrials 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRNT icon
26
Kornit Digital
KRNT
$677M
$61M 1.49%
2,563,859
-46,269
-2% -$984K
DOX icon
27
Amdocs
DOX
$6.03B
$59M 1.45%
1,090,517
+737,705
+209% +$41.5M
IHI icon
28
iShares US Medical Devices ETF
IHI
$3.17B
$55.6M 1.36%
+1,440,000
New +$52.3M
LYV icon
29
Live Nation Entertainment
LYV
$42.9B
$53.6M 1.31%
844,000
+82,749
+11% +$4.69M
VTRS icon
30
Viatris
VTRS
$20.8B
$48.5M 1.19%
1,712,560
+699,932
+69% +$20.4M
TEVA icon
31
Teva Pharmaceuticals
TEVA
$40.4B
$48.4M 1.19%
3,087,266
-695,030
-18% -$12.3M
MOS icon
32
The Mosaic Company
MOS
$7.19B
$48.1M 1.18%
1,759,876
+407,876
+30% +$12.4M
AER icon
33
AerCap
AER
$23.4B
$47.6M 1.17%
1,022,376
-22,188
-2% -$1M
NTR icon
34
Nutrien
NTR
$33.9B
$44.9M 1.1%
846,383
+346,383
+69% +$18M
DBJP icon
35
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$675M
$44.7M 1.09%
1,122,567
-1,761,585
-61% -$68.4M
DK icon
36
Delek US
DK
$3.98B
$38.2M 0.94%
1,049,314
+289,314
+38% +$9.85M
IBB icon
37
iShares Biotechnology ETF
IBB
$9.45B
$35.3M 0.86%
315,776
-422,758
-57% -$46.4M
ISRG icon
38
Intuitive Surgical
ISRG
$127B
$30.8M 0.75%
162,000
+157,170
+3,254% +$27.9M
IFF icon
39
International Flavors & Fragrances
IFF
$20.3B
$30.3M 0.74%
235,171
-15,829
-6% -$2.1M
IBUY icon
40
Amplify Online Retail ETF
IBUY
$112M
$29.4M 0.72%
600,000
+350,000
+140% +$16.4M
CHIQ icon
41
Global X MSCI China Consumer Discretionary ETF
CHIQ
$131M
$29M 0.71%
1,739,551
-40,449
-2% -$612K
BAC icon
42
Bank of America
BAC
$429B
$28.1M 0.69%
1,020,000
-948,809
-48% -$26.8M
LNG icon
43
Cheniere Energy
LNG
$54.2B
$28M 0.69%
410,000
+405,500
+9,011% +$26.7M
JPM icon
44
JPMorgan Chase
JPM
$916B
$27.8M 0.68%
+275,000
New +$28.3M
KRE icon
45
State Street SPDR S&P Regional Banking ETF
KRE
$4.51B
$27.5M 0.67%
+535,000
New +$28.6M
MGIC
46
DELISTED
Magic Software Enterprises
MGIC
$20.6M 0.5%
2,462,372
-49,718
-2% -$414K
URGN icon
47
UroGen Pharma
URGN
$1.97B
$20.5M 0.5%
554,974
+155,712
+39% +$6.53M
FTNT icon
48
Fortinet
FTNT
$112B
$18.5M 0.45%
+1,100,000
New +$17.5M
ALLT icon
49
Allot
ALLT
$362M
$17.2M 0.42%
2,161,929
-46,064
-2% -$331K
NVMI
50
Nova
NVMI
$11.7B
$17.2M 0.42%
681,517
-197,831
-22% -$4.79M

Similar funds

Clal Insurance's Q1 2019 Portfolio in Review

As of Q1 2019, Clal Insurance held 117 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Clal Insurance withdrew a net $328M in Q1 2019, closing 11 positions and reducing 42 holdings. Its most notable exit was Orbotech Ltd, an estimated $91M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Clal Insurance opened a new position in State Street Industrial Select Sector SPDR ETF worth $131M.

  • Clal Insurance's largest Q1 2019 buy was State Street Industrial Select Sector SPDR ETF: 1,750,000 shares worth $131M.
  • Clal Insurance added most to State Street Financial Select Sector SPDR ETF in Q1 2019, an estimated $51.6M increase.
  • Clal Insurance's biggest Q1 2019 reduction was Vanguard S&P 500 ETF, cutting an estimated $548M.
  • Clal Insurance fully exited Orbotech Ltd in Q1 2019, selling an estimated $91M.
  • Clal Insurance's ten largest holdings make up 42% of its $4.08B portfolio in Q1 2019.
  • Clal Insurance opened 17 new positions and closed 11 in Q1 2019.
  • Clal Insurance's portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Clal Insurance's 13F filing for Q1 2019, filed 14 May 2019.